{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:46:17Z","timestamp":1792597577528,"version":"4.5.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Cardiol"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1038\/nrcardio.2014.37","type":"journal-article","created":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T04:00:57Z","timestamp":1396324857000},"page":"364-370","source":"Crossref","is-referenced-by-count":200,"title":["Pathophysiology and epidemiology of peripartum cardiomyopathy"],"prefix":"10.1038","volume":"11","author":[{"given":"Denise","family":"Hilfiker-Kleiner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Sliwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,4,1]]},"reference":[{"key":"BFnrcardio201437_CR1","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1001\/jama.283.9.1183","volume":"283","author":"GD Pearson","year":"2000","unstructured":"Pearson, G. D.  et al. Peripartum cardiomyopathy: National Heart, Lung, and Blood Institute and Office of Rare Diseases (National Institutes of Health) workshop recommendations and review. JAMA 283, 1183\u20131188 (2000).","journal-title":"JAMA"},{"key":"BFnrcardio201437_CR2","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2217\/14796678.5.2.175","volume":"5","author":"T Selle","year":"2009","unstructured":"Selle, T., Renger, I., Labidi, S., Bultmann, I. & Hilfiker-Kleiner, D. Reviewing peripartum cardiomyopathy: current state of knowledge. Future Cardiol. 5, 175\u2013189 (2009).","journal-title":"Future Cardiol."},{"key":"BFnrcardio201437_CR3","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S0140-6736(06)69253-2","volume":"368","author":"K Sliwa","year":"2006","unstructured":"Sliwa, K., Fett, J. & Elkayam, U. Peripartum cardiomyopathy. Lancet 368, 687\u2013693 (2006).","journal-title":"Lancet"},{"key":"BFnrcardio201437_CR4","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1093\/eurjhf\/hfq120","volume":"12","author":"K Sliwa","year":"2010","unstructured":"Sliwa, K.  et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on Peripartum Cardiomyopathy. Eur. Heart J. 12, 767\u2013778 (2010).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio201437_CR5","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1161\/01.CIR.44.5.964","volume":"44","author":"JG Demakis","year":"1971","unstructured":"Demakis, J. G. & Rahimtoola, S. H. Peripartum cardiomyopathy. Circulation 44, 964\u2013968 (1971).","journal-title":"Circulation"},{"key":"BFnrcardio201437_CR6","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1161\/01.CIR.0000162478.36652.7E","volume":"111","author":"U Elkayam","year":"2005","unstructured":"Elkayam, U.  et al. Pregnancy-associated cardiomyopathy: clinical characteristics and a comparison between early and late presentation. Circulation 111, 2050\u20132055 (2005).","journal-title":"Circulation"},{"key":"BFnrcardio201437_CR7","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1007\/s00395-013-0366-9","volume":"108","author":"A Haghikia","year":"2013","unstructured":"Haghikia, A.  et al. Phenotyping and outcome on contemporary management in a German cohort of patients with peripartum cardiomyopathy. Basic Res. Cardiol. 108, 366 (2013).","journal-title":"Basic Res. Cardiol."},{"key":"BFnrcardio201437_CR8","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1016\/j.cardfail.2009.03.008","volume":"15","author":"S Goland","year":"2009","unstructured":"Goland, S.  et al. Clinical profile and predictors of complications in peripartum cardiomyopathy. J. Card. Fail. 15, 645\u2013650 (2009).","journal-title":"J. Card. Fail."},{"key":"BFnrcardio201437_CR9","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/eurheartj\/ehi481","volume":"27","author":"K Sliwa","year":"2006","unstructured":"Sliwa, K.  et al. Peripartum cardiomyopathy: inflammatory markers as predictors of outcome in 100 prospectively studied patients. Eur. Heart J. 27, 441\u2013446 (2006).","journal-title":"Eur. Heart J."},{"key":"BFnrcardio201437_CR10","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1172\/JCI64365","volume":"123","author":"J Halkein","year":"2013","unstructured":"Halkein, J.  et al. MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy. J. Clin. Invest. 123, 2143\u20132154 (2013).","journal-title":"J. Clin. Invest."},{"key":"BFnrcardio201437_CR11","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.cell.2006.12.036","volume":"128","author":"D Hilfiker-Kleiner","year":"2007","unstructured":"Hilfiker-Kleiner, D.  et al. A cathepsin D-cleaved 16 kDa form of prolactin mediates postpartum cardiomyopathy. Cell 128, 589\u2013600 (2007).","journal-title":"Cell"},{"key":"BFnrcardio201437_CR12","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature11040","volume":"485","author":"IS Patten","year":"2012","unstructured":"Patten, I. S.  et al. Cardiac angiogenic imbalance leads to peripartum cardiomyopathy. Nature 485, 333\u2013338 (2012).","journal-title":"Nature"},{"key":"BFnrcardio201437_CR13","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.ejheart.2008.07.005","volume":"10","author":"O Forster","year":"2008","unstructured":"Forster, O.  et al. Reversal of IFN-\u03b3, oxLDL and prolactin serum levels correlate with clinical improvement in patients with peripartum cardiomyopathy. Eur. J. Heart Fail. 10, 861\u2013868 (2008).","journal-title":"Eur. J. Heart Fail."},{"key":"BFnrcardio201437_CR14","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1093\/cvr\/cvu010","volume":"101","author":"M Ricke-Hoch","year":"2014","unstructured":"Ricke-Hoch, M.  et al. Opposing roles of Akt and STAT3 in protection of the maternal heart from peripartum stress. Cardiovasc. Res. 101, 587\u2013596 (2014).","journal-title":"Cardiovasc. Res."},{"key":"BFnrcardio201437_CR15","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1253\/circj.CJ-10-1214","volume":"75","author":"CA Kamiya","year":"2011","unstructured":"Kamiya, C. A.  et al. Different characteristics of peripartum cardiomyopathy between patients complicated with and without hypertensive disorders: results from the Japanese Nationwide survey of peripartum cardiomyopathy. Circ. J. 75, 1975\u20131981 (2011).","journal-title":"Circ. J."},{"key":"BFnrcardio201437_CR16","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.amjcard.2007.02.092","volume":"100","author":"SS Brar","year":"2007","unstructured":"Brar, S. S.  et al. Incidence, mortality, and racial differences in peripartum cardiomyopathy. Am. J. Cardiol. 100, 302\u2013304 (2007).","journal-title":"Am. J. Cardiol."},{"key":"BFnrcardio201437_CR17","first-page":"46","volume":"85","author":"JD Fett","year":"2002","unstructured":"Fett, J. D. Peripartum cardiomyopathy: insights from Haiti regarding a disease of unknown etiology. Minn. Med. 85, 46\u201348 (2002).","journal-title":"Minn. Med."},{"key":"BFnrcardio201437_CR18","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.4065\/80.12.1602","volume":"80","author":"JD Fett","year":"2005","unstructured":"Fett, J. D., Christie, L. G., Carraway, R. D. & Murphy, J. G. Five-year prospective study of the incidence and prognosis of peripartum cardiomyopathy at a single institution. Mayo Clin. Proc. 80, 1602\u20131606 (2005).","journal-title":"Mayo Clin. Proc."},{"key":"BFnrcardio201437_CR19","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1097\/AOG.0b013e3181c4ee8c","volume":"115","author":"EV Kuklina","year":"2010","unstructured":"Kuklina, E. V. & Callaghan, W. M. Cardiomyopathy and other myocardial disorders among hospitalizations for pregnancy in the United States: 2004\u20132006. Obstet. Gynecol. 115, 93\u2013100 (2010).","journal-title":"Obstet. Gynecol."},{"key":"BFnrcardio201437_CR20","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.ijgo.2005.05.004","volume":"90","author":"JD Fett","year":"2005","unstructured":"Fett, J. D.  et al. Unrecognized peripartum cardiomyopathy in Haitian women. Int. J. Gynaecol. Obstet. 90, 161\u2013166 (2005).","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"BFnrcardio201437_CR21","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1177\/004947559502500310","volume":"25","author":"D Desai","year":"1995","unstructured":"Desai, D., Moodley, J. & Naidoo, D. Peripartum cardiomyopathy: experiences at King Edward VIII Hospital, Durban, South Africa and a review of the literature. Trop. Doct. 25, 118\u2013123 (1995).","journal-title":"Trop. Doct."},{"key":"BFnrcardio201437_CR22","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1097\/01.AOG.0000161382.30233.ba","volume":"105","author":"JB Chapa","year":"2005","unstructured":"Chapa, J. B.  et al. Prognostic value of echocardiography in peripartum cardiomyopathy. Obstet. Gynecol. 105, 1303\u20131308 (2005).","journal-title":"Obstet. Gynecol."},{"key":"BFnrcardio201437_CR23","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1016\/j.jacc.2009.09.043","volume":"55","author":"MB Gentry","year":"2010","unstructured":"Gentry, M. B.  et al. African-American women have a higher risk for developing peripartum cardiomyopathy. J. Am. Coll. Cardiol. 55, 654\u2013659 (2010).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201437_CR24","doi-asserted-by":"publisher","first-page":"171.e1","DOI":"10.1016\/j.ajog.2009.04.037","volume":"201","author":"KA Modi","year":"2009","unstructured":"Modi, K. A., Illum, S., Jariatul, K., Caldito, G. & Reddy, P. C. Poor outcome of indigent patients with peripartum cardiomyopathy in the United States. Am. J. Obstet. Gynecol. 201, 171.e1\u2013e5 (2009).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"BFnrcardio201437_CR25","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.cardfail.2013.03.004","volume":"19","author":"S Goland","year":"2013","unstructured":"Goland, S., Modi, K., Hatamizadeh, P. & Elkayam, U. Differences in clinical profile of African\u2013American women with peripartum cardiopmyopathy in the United States. J. Card. Fail. 19, 214\u2013218 (2013).","journal-title":"J. Card. Fail."},{"key":"BFnrcardio201437_CR26","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1136\/heartjnl-2012-302760","volume":"99","author":"LA Blauwet","year":"2013","unstructured":"Blauwet, L. A.  et al. Predictors of outcome in 176 South African patients with peripartum cardiomyopathy. Heart 99, 308\u2013313 (2013).","journal-title":"Heart"},{"key":"BFnrcardio201437_CR27","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1016\/j.amjcard.2006.01.039","volume":"97","author":"LM Mielniczuk","year":"2006","unstructured":"Mielniczuk, L. M.  et al. Frequency of peripartum cardiomyopathy. Am. J. Cardiol. 97, 1765\u20131768 (2006).","journal-title":"Am. J. Cardiol."},{"key":"BFnrcardio201437_CR28","unstructured":"European Society of Cardiology. PeriPartum CardioMyopathy (PPCM) Registry \n                    [online]\n                    \n                  , (2014)."},{"key":"BFnrcardio201437_CR29","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.jacc.2011.03.047","volume":"58","author":"U Elkayam","year":"2011","unstructured":"Elkayam, U. Clinical characteristics of peripartum cardiomyopathy in the United States: diagnosis, prognosis, and management. J. Am. Coll. Cardiol. 58, 659\u2013670 (2011).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201437_CR30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.ijcard.2010.08.065","volume":"154","author":"JG Safirstein","year":"2012","unstructured":"Safirstein, J. G.  et al. Predictors of left ventricular recovery in a cohort of peripartum cardiomyopathy patients recruited via the internet. Int. J. Cardiol. 154, 27\u201331 (2012).","journal-title":"Int. J. Cardiol."},{"key":"BFnrcardio201437_CR31","doi-asserted-by":"publisher","unstructured":"Sliwa, K.  et al. EURObservational Research Programme: a worldwide registry on peripartum cardiomyopathy (PPCM) in conjunction with the Heart Failure Association of the European Society of Cardiology Working Group on PPCM. Eur. J. Heart Fail. \n                    http:\/\/dx.doi.org\/10.1002\/ejhf.68\n                    \n                  .","DOI":"10.1002\/ejhf.68"},{"key":"BFnrcardio201437_CR32","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1016\/0002-8703(95)90032-2","volume":"129","author":"W Pearl","year":"1995","unstructured":"Pearl, W. Familial occurrence of peripartum cardiomyopathy. Am. Heart J. 129, 421\u2013422 (1995).","journal-title":"Am. Heart J."},{"key":"BFnrcardio201437_CR33","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1001\/archinte.1963.03620290117016","volume":"111","author":"JA Pierce","year":"1963","unstructured":"Pierce, J. A., Price, B. O. & Joyce, J. W. Familial occurrence of postpartal heart failure. Arch. Intern. Med. 111, 651\u2013655 (1963).","journal-title":"Arch. Intern. Med."},{"key":"BFnrcardio201437_CR34","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/1752-1947-4-80","volume":"4","author":"GP Meyer","year":"2010","unstructured":"Meyer, G. P.  et al. Bromocriptine treatment associated with recovery from peripartum cardiomyopathy in siblings: two case reports. J. Med. Case Reports 4, 80 (2010).","journal-title":"J. Med. Case Reports"},{"key":"BFnrcardio201437_CR35","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/S0167-5273(02)00357-1","volume":"86","author":"JD Fett","year":"2002","unstructured":"Fett, J. D., Sundstrom, B. J., Etta King, M. & Ansari, A. A. Mother\u2013daughter peripartum cardiomyopathy. Int. J. Cardiol. 86, 331\u2013332 (2002).","journal-title":"Int. J. Cardiol."},{"key":"BFnrcardio201437_CR36","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1161\/CIRCULATIONAHA.109.929646","volume":"121","author":"K van Spaendonck-Zwarts","year":"2010","unstructured":"van Spaendonck-Zwarts, K.  et al. Peripartum cardiomyopathy as part of familial dilated cardiomyopathy. Circulation 121, 2169\u20132175 (2010).","journal-title":"Circulation"},{"key":"BFnrcardio201437_CR37","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1161\/CIRCULATIONAHA.109.931220","volume":"121","author":"A Morales","year":"2010","unstructured":"Morales, A.  et al. Rare variant mutations in pregnancy-associated or peripartum cardiomyopathy. Circulation 121, 2176\u20132182 (2010).","journal-title":"Circulation"},{"key":"BFnrcardio201437_CR38","doi-asserted-by":"publisher","unstructured":"van Spaendonck-Zwarts, K. Y.  et al. Titin gene mutations are common in families with both peripartum cardiomyopathy and dilated cardiomyopathy. Eur. Heart J. \n                    http:\/\/dx.doi.org\/10.1093\/eurheartj\/ehu050\n                    \n                  .","DOI":"10.1093\/eurheartj\/ehu050"},{"key":"BFnrcardio201437_CR39","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.ijcard.2005.05.057","volume":"109","author":"A Bahl","year":"2006","unstructured":"Bahl, A., Swamy, A., Sharma, Y. & Kumar, N. Isolated noncompaction of left ventricle presenting as peripartum cardiomyopathy. Int. J. Cardiol. 109, 422\u2013423 (2006).","journal-title":"Int. J. Cardiol."},{"key":"BFnrcardio201437_CR40","doi-asserted-by":"publisher","first-page":"e65","DOI":"10.1016\/j.ijcard.2011.06.073","volume":"154","author":"B Lea","year":"2012","unstructured":"Lea, B., Bailey, A. L., Wiisanen, M. E., Attili, A. & Rajagopalan, N. Left ventricular noncompaction presenting as peripartum cardiomyopathy. Int. J. Cardiol. 154, e65\u2013e66 (2012).","journal-title":"Int. J. Cardiol."},{"key":"BFnrcardio201437_CR41","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1016\/j.ijcard.2008.08.025","volume":"139","author":"KH Rehfeldt","year":"2010","unstructured":"Rehfeldt, K. H., Pulido, J. N., Mauermann, W. J. & Click, R. L. Left ventricular hypertrabeculation\/noncompaction in a patient with peripartum cardiomyopathy. Int. J. Cardiol. 139, e18\u2013e20 (2010).","journal-title":"Int. J. Cardiol."},{"key":"BFnrcardio201437_CR42","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s11897-012-0095-7","volume":"9","author":"D Hilfiker-Kleiner","year":"2012","unstructured":"Hilfiker-Kleiner, D., Struman, I., Hoch, M., Podewski, E. & Sliwa, K. 16-kDa prolactin and bromocriptine in postpartum cardiomyopathy. Curr. Heart Fail. Rep. 9, 174\u2013182 (2012).","journal-title":"Curr. Heart Fail. Rep."},{"key":"BFnrcardio201437_CR43","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1046\/j.1365-2265.2002.01638.x","volume":"57","author":"V Toescu","year":"2002","unstructured":"Toescu, V., Nuttall, S. L., Martin, U., Kendall, M. J. & Dunne, F. Oxidative stress and normal pregnancy. Clin. Endocrinol. (Oxf.) 57, 609\u2013613 (2002).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BFnrcardio201437_CR44","doi-asserted-by":"publisher","first-page":"5155","DOI":"10.1242\/jcs.01396","volume":"117","author":"M Lkhider","year":"2004","unstructured":"Lkhider, M., Castino, R., Bouguyon, E., Isidoro, C. & Ollivier-Bousquet, M. Cathepsin D released by lactating rat mammary epithelial cells is involved in prolactin cleavage under physiological conditions. J. Cell Sci. 117, 5155\u20135164 (2004).","journal-title":"J. Cell Sci."},{"key":"BFnrcardio201437_CR45","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1210\/endo-129-2-896","volume":"129","author":"N Ferrara","year":"1991","unstructured":"Ferrara, N., Clapp, C. & Weiner, R. The 16K fragment of prolactin specifically inhibits basal or fibroblast growth factor stimulated growth of capillary endothelial cells. Endocrinology 129, 896\u2013900 (1991).","journal-title":"Endocrinology"},{"key":"BFnrcardio201437_CR46","doi-asserted-by":"publisher","first-page":"2522","DOI":"10.1210\/me.2004-0200","volume":"18","author":"D Piwnica","year":"2004","unstructured":"Piwnica, D.  et al. Cathepsin D processes human prolactin into multiple 16K-like N-terminal fragments: study of their antiangiogenic properties and physiological relevance. Mol. Endocrinol. 18, 2522\u20132542 (2004).","journal-title":"Mol. Endocrinol."},{"key":"BFnrcardio201437_CR47","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.1242\/jcs.02887","volume":"119","author":"Y Macotela","year":"2006","unstructured":"Macotela, Y.  et al. Matrix metalloproteases from chondrocytes generate an antiangiogenic 16 kDa prolactin. J. Cell Sci. 119, 1790\u20131800 (2006).","journal-title":"J. Cell Sci."},{"key":"BFnrcardio201437_CR48","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1210\/me.2004-0515","volume":"19","author":"SP Tabruyn","year":"2005","unstructured":"Tabruyn, S. P., Nguyen, N. Q., Cornet, A. M., Martial, J. A. & Struman, I. The antiangiogenic factor, 16-kDa human prolactin, induces endothelial cell cycle arrest by acting at both the G0\u2013G1 and the G2\u2013M phases. Mol. Endocrinol. 19, 1932\u20131942 (2005).","journal-title":"Mol. Endocrinol."},{"key":"BFnrcardio201437_CR49","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1210\/me.13.5.692","volume":"13","author":"G D'Angelo","year":"1999","unstructured":"D'Angelo, G.  et al. 16K human prolactin inhibits vascular endothelial growth factor-induced activation of Ras in capillary endothelial cells. Mol. Endocrinol. 13, 692\u2013704 (1999).","journal-title":"Mol. Endocrinol."},{"key":"BFnrcardio201437_CR50","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1210\/me.2003-0132","volume":"17","author":"SP Tabruyn","year":"2003","unstructured":"Tabruyn, S. P.  et al. The antiangiogenic factor 16K human prolactin induces caspase-dependent apoptosis by a mechanism that requires activation of nuclear factor-\u03baB. Mol. Endocrinol. 17, 1815\u20131823 (2003).","journal-title":"Mol. Endocrinol."},{"key":"BFnrcardio201437_CR51","doi-asserted-by":"publisher","first-page":"11045","DOI":"10.1158\/0008-5472.CAN-07-0986","volume":"67","author":"SH Lee","year":"2007","unstructured":"Lee, S. H., Kunz, J., Lin, S. H. & Yu-Lee, L. Y. 16-kDa prolactin inhibits endothelial cell migration by down-regulating the Ras\u2013Tiam1\u2013Rac1\u2013Pak1 signaling pathway. Cancer Res. 67, 11045\u201311053 (2007).","journal-title":"Cancer Res."},{"key":"BFnrcardio201437_CR52","doi-asserted-by":"publisher","first-page":"5714","DOI":"10.1210\/en.2004-0647","volume":"145","author":"C Gonzalez","year":"2004","unstructured":"Gonzalez, C.  et al. 16K-prolactin inhibits activation of endothelial nitric oxide synthase, intracellular calcium mobilization, and endothelium-dependent vasorelaxation. Endocrinology 145, 5714\u20135722 (2004).","journal-title":"Endocrinology"},{"key":"BFnrcardio201437_CR53","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1038\/labinvest.3700662","volume":"87","author":"C Gonzalez","year":"2007","unstructured":"Gonzalez, C.  et al. Elevated vasoinhibins may contribute to endothelial cell dysfunction and low birth weight in preeclampsia. Lab. Invest. 87, 1009\u20131017 (2007).","journal-title":"Lab. Invest."},{"key":"BFnrcardio201437_CR54","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1038\/sj.mt.6300294","volume":"15","author":"NQ Nguyen","year":"2007","unstructured":"Nguyen, N. Q.  et al. Inhibition of tumor growth and metastasis establishment by adenovirus-mediated gene transfer delivery of the antiangiogenic factor 16K hPRL. Mol. Ther. 15, 2094\u20132100 (2007).","journal-title":"Mol. Ther."},{"key":"BFnrcardio201437_CR55","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1016\/j.ejheart.2008.09.001","volume":"10","author":"D Habedank","year":"2008","unstructured":"Habedank, D.  et al. Recovery from peripartum cardiomyopathy after treatment with bromocriptine. Eur. J. Heart Fail. 10, 1149\u20131151 (2008).","journal-title":"Eur. J. Heart Fail."},{"key":"BFnrcardio201437_CR56","doi-asserted-by":"publisher","first-page":"2354","DOI":"10.1016\/j.jacc.2007.10.006","volume":"50","author":"D Hilfiker-Kleiner","year":"2007","unstructured":"Hilfiker-Kleiner, D.  et al. Recovery from postpartum cardiomyopathy in 2 patients by blocking prolactin release with bromocriptine. J. Am. Coll. Cardiol. 50, 2354\u20132355 (2007).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201437_CR57","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1161\/CIRCULATIONAHA.109.901496","volume":"121","author":"K Sliwa","year":"2010","unstructured":"Sliwa, K.  et al. Evaluation of bromocriptine in the treatment of acute severe peripartum cardiomyopathy: a proof-of-concept pilot study. Circulation 121, 1465\u20131473 (2010).","journal-title":"Circulation"},{"key":"BFnrcardio201437_CR58","unstructured":"US National Library of Medicine. ClinicalTrials.gov \n                    [online]\n                    \n                  , (2012)."},{"key":"BFnrcardio201437_CR59","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1016\/j.jacc.2013.08.717","volume":"62","author":"N Bello","year":"2013","unstructured":"Bello, N., Rendon, I. S. & Arany, Z. The relationship between pre-eclampsia and peripartum cardiomyopathy: a systematic review and meta-analysis. J. Am. Coll. Cardiol. 62, 1715\u20131723 (2013).","journal-title":"J. Am. Coll. Cardiol."},{"key":"BFnrcardio201437_CR60","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1161\/CIRCULATIONAHA.111.054361","volume":"125","author":"S Rana","year":"2012","unstructured":"Rana, S.  et al. Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia. Circulation 125, 911\u2013919 (2012).","journal-title":"Circulation"},{"key":"BFnrcardio201437_CR61","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1161\/CIRCIMAGING.112.973818","volume":"5","author":"S Shahul","year":"2012","unstructured":"Shahul, S.  et al. Subclinical left ventricular dysfunction in preeclamptic women with preserved left ventricular ejection fraction: a 2D speckle-tracking imaging study. Circ. Cardiovasc. Imaging 5, 734\u2013739 (2012).","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"BFnrcardio201437_CR62","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1161\/CIRCULATIONAHA.109.853127","volume":"123","author":"CE Powe","year":"2011","unstructured":"Powe, C. E., Levine, R. J. & Karumanchi, S. A. Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease. Circulation 123, 2856\u20132869 (2011).","journal-title":"Circulation"},{"key":"BFnrcardio201437_CR63","doi-asserted-by":"publisher","first-page":"809","DOI":"10.2217\/fca.13.63","volume":"9","author":"JD Fett","year":"2013","unstructured":"Fett, J. D. Earlier detection can help avoid many serious complications of peripartum cardiomyopathy. Future Cardiol. 9, 809\u2013816 (2013).","journal-title":"Future Cardiol."},{"key":"BFnrcardio201437_CR64","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1056\/NEJM200105243442101","volume":"344","author":"U Elkayam","year":"2001","unstructured":"Elkayam, U.  et al. Maternal and fetal outcomes of subsequent pregnancies in women with peripartum cardiomyopathy. N. Engl. J. Med. 344, 1567\u20131571 (2001).","journal-title":"N. Engl. J. Med."},{"key":"BFnrcardio201437_CR65","doi-asserted-by":"publisher","first-page":"1564","DOI":"10.1152\/japplphysiol.00027.2012","volume":"112","author":"E Chung","year":"2012","unstructured":"Chung, E., Yeung, F. & Leinwand, L. A. Akt and MAPK signaling mediate pregnancy-induced cardiac adaptation. J. Appl. Physiol. (1985) 112, 1564\u20131575 (2012).","journal-title":"J. Appl. Physiol. (1985)"},{"key":"BFnrcardio201437_CR66","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1161\/01.RES.0000170652.71414.16","volume":"96","author":"M Eghbali","year":"2005","unstructured":"Eghbali, M.  et al. Molecular and functional signature of heart hypertrophy during pregnancy. Circ. Res. 96, 1208\u20131216 (2005).","journal-title":"Circ. Res."},{"key":"BFnrcardio201437_CR67","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.1093\/eurheartj\/ehr485","volume":"33","author":"K Walenta","year":"2012","unstructured":"Walenta, K.  et al. Circulating microparticles as indicators of peripartum cardiomyopathy. Eur. Heart J. 33, 1469\u20131479 (2012).","journal-title":"Eur. Heart J."}],"container-title":["Nature Reviews Cardiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrcardio.2014.37.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrcardio.2014.37","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrcardio.2014.37.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T23:54:55Z","timestamp":1684454095000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrcardio.2014.37"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,1]]},"references-count":67,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["BFnrcardio201437"],"URL":"https:\/\/doi.org\/10.1038\/nrcardio.2014.37","relation":{},"ISSN":["1759-5002","1759-5010"],"issn-type":[{"value":"1759-5002","type":"print"},{"value":"1759-5010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,1]]}}}